HTR2A and diabetes mellitus: These findings suggest that, in experimental long-term (eight-week) diabetes, the serotonergic effects on bradycardia are mediated through activation of the 5-HT1 receptors but not through activation of the 5-HT2 or 5-HT3 receptors.